vs
Side-by-side financial comparison of Spero Therapeutics, Inc. (SPRO) and WILLAMETTE VALLEY VINEYARDS INC (WVVI). Click either name above to swap in a different company.
Spero Therapeutics, Inc. is the larger business by last-quarter revenue ($12.6M vs $11.1M, roughly 1.1× WILLAMETTE VALLEY VINEYARDS INC). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 7.3%, a 243.4% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs -1.5%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 12.3%).
Willamette Valley Vineyards is an American winery located in Turner, Oregon. Named after Oregon's Willamette Valley, the winery is the leading producer of Willamette Valley-appellated Pinot Noir in Oregon, and also produces Chardonnay and Pinot Gris. In 2016, the winery was the largest producer of Riesling wine in the Willamette Valley.
SPRO vs WVVI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.6M | $11.1M |
| Net Profit | $31.5M | $811.0K |
| Gross Margin | — | 58.6% |
| Operating Margin | — | 2.2% |
| Net Margin | 250.7% | 7.3% |
| Revenue YoY | 24080.8% | -1.5% |
| Net Profit YoY | 250.9% | 65.2% |
| EPS (diluted) | $0.56 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.6M | $11.1M | ||
| Q3 25 | $0 | $8.4M | ||
| Q2 25 | $0 | $10.2M | ||
| Q1 25 | $12.0K | $7.5M | ||
| Q4 24 | $52.0K | $11.3M | ||
| Q3 24 | $65.0K | $9.4M | ||
| Q2 24 | $114.0K | $10.3M | ||
| Q1 24 | $140.0K | $8.8M |
| Q4 25 | $31.5M | $811.0K | ||
| Q3 25 | $-7.4M | $-1.1M | ||
| Q2 25 | $-1.7M | $92.8K | ||
| Q1 25 | $-13.9M | $-729.0K | ||
| Q4 24 | — | $490.9K | ||
| Q3 24 | $-17.1M | $-282.9K | ||
| Q2 24 | $-17.9M | $196.0K | ||
| Q1 24 | $-12.7M | $-521.8K |
| Q4 25 | — | 58.6% | ||
| Q3 25 | — | 59.9% | ||
| Q2 25 | — | 61.0% | ||
| Q1 25 | — | 63.1% | ||
| Q4 24 | — | 58.9% | ||
| Q3 24 | — | 62.0% | ||
| Q2 24 | — | 62.6% | ||
| Q1 24 | — | 59.9% |
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | -14.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | -122758.3% | -11.5% | ||
| Q4 24 | — | 6.9% | ||
| Q3 24 | -28604.6% | -1.5% | ||
| Q2 24 | -16720.2% | 5.2% | ||
| Q1 24 | -9987.1% | -6.8% |
| Q4 25 | 250.7% | 7.3% | ||
| Q3 25 | — | -13.1% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | -115550.0% | -9.7% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | -26380.0% | -3.0% | ||
| Q2 24 | -15668.4% | 1.9% | ||
| Q1 24 | -9049.3% | -5.9% |
| Q4 25 | $0.56 | — | ||
| Q3 25 | $-0.13 | — | ||
| Q2 25 | $-0.03 | — | ||
| Q1 25 | $-0.25 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.32 | — | ||
| Q2 24 | $-0.33 | — | ||
| Q1 24 | $-0.24 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $40.3M | $410.9K |
| Total DebtLower is stronger | — | $14.0M |
| Stockholders' EquityBook value | $59.0M | $66.2M |
| Total Assets | $68.9M | $107.7M |
| Debt / EquityLower = less leverage | — | 0.21× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $40.3M | $410.9K | ||
| Q3 25 | $48.6M | $372.6K | ||
| Q2 25 | $31.2M | $350.6K | ||
| Q1 25 | $48.9M | $332.9K | ||
| Q4 24 | $52.9M | $320.9K | ||
| Q3 24 | $76.3M | $303.2K | ||
| Q2 24 | $63.5M | $279.8K | ||
| Q1 24 | $82.3M | $256.5K |
| Q4 25 | — | $14.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $12.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $59.0M | $66.2M | ||
| Q3 25 | $26.5M | $67.6M | ||
| Q2 25 | $32.8M | $68.6M | ||
| Q1 25 | $33.8M | $68.5M | ||
| Q4 24 | $46.1M | $69.2M | ||
| Q3 24 | $65.5M | $71.0M | ||
| Q2 24 | $80.5M | $71.3M | ||
| Q1 24 | $96.2M | $71.1M |
| Q4 25 | $68.9M | $107.7M | ||
| Q3 25 | $54.2M | $107.6M | ||
| Q2 25 | $62.1M | $106.6M | ||
| Q1 25 | $77.7M | $108.2M | ||
| Q4 24 | $110.5M | $109.0M | ||
| Q3 24 | $135.2M | $107.3M | ||
| Q2 24 | $149.9M | $106.5M | ||
| Q1 24 | $167.7M | $106.2M |
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.4M | $-344.5K |
| Free Cash FlowOCF − Capex | — | $-532.1K |
| FCF MarginFCF / Revenue | — | -4.8% |
| Capex IntensityCapex / Revenue | — | 1.7% |
| Cash ConversionOCF / Net Profit | -0.26× | -0.42× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-2.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.4M | $-344.5K | ||
| Q3 25 | $17.4M | $-1.4M | ||
| Q2 25 | $-17.7M | $1.3M | ||
| Q1 25 | $-4.0M | $-1.3M | ||
| Q4 24 | $-23.4M | $-1.1M | ||
| Q3 24 | $12.8M | $52.2K | ||
| Q2 24 | $-18.7M | $800.7K | ||
| Q1 24 | $5.9M | $-3.0M |
| Q4 25 | — | $-532.1K | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $-1.4M | ||
| Q4 24 | — | $-1.4M | ||
| Q3 24 | — | $-373.9K | ||
| Q2 24 | — | $45.8K | ||
| Q1 24 | — | $-3.3M |
| Q4 25 | — | -4.8% | ||
| Q3 25 | — | -18.1% | ||
| Q2 25 | — | 12.2% | ||
| Q1 25 | — | -19.0% | ||
| Q4 24 | — | -12.8% | ||
| Q3 24 | — | -4.0% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | -37.7% |
| Q4 25 | — | 1.7% | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 7.3% | ||
| Q1 24 | — | 3.5% |
| Q4 25 | -0.26× | -0.42× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 14.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -2.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 4.09× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SPRO
Segment breakdown not available.
WVVI
| Direct Sales | $5.8M | 52% |
| Distributor Sales | $5.3M | 48% |
